These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24233060)

  • 1. Dexamethasone otoprotection in a multidose cisplatin ototoxicity mouse model.
    Hughes AL; Hussain N; Pafford R; Parham K
    Otolaryngol Head Neck Surg; 2014 Jan; 150(1):115-20. PubMed ID: 24233060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can intratympanic dexamethasone protect against cisplatin ototoxicity in mice with age-related hearing loss?
    Parham K
    Otolaryngol Head Neck Surg; 2011 Oct; 145(4):635-40. PubMed ID: 21572077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model.
    Murphy D; Daniel SJ
    Otolaryngol Head Neck Surg; 2011 Sep; 145(3):452-7. PubMed ID: 21521888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intratympanic dexamethasone administration on cisplatin-induced ototoxicity in adult guinea pigs.
    Shafik AG; Elkabarity RH; Thabet MT; Soliman NB; Kalleny NK
    Auris Nasus Larynx; 2013 Feb; 40(1):51-60. PubMed ID: 22884636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auditory function after a prolonged course of ciprofloxacin-dexamethasone otic suspension in a murine model.
    Kavanagh KR; Parham K; Schoem SR
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):238-41. PubMed ID: 19289700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections.
    Hill GW; Morest DK; Parham K
    Otol Neurotol; 2008 Oct; 29(7):1005-11. PubMed ID: 18716567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-Induced Ototoxicity and the Effects of Intratympanic Diltiazem in a Mouse Model.
    Naples JG; Parham K
    Otolaryngol Head Neck Surg; 2016 Jan; 154(1):144-9. PubMed ID: 26419839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic Diltiazem-Chitosan Hydrogel as an Otoprotectant Against Cisplatin-Induced Ototoxicity in a Mouse Model.
    Naples JG; Ruckenstein MJ; Singh J; Cox BC; Li D
    Otol Neurotol; 2020 Jan; 41(1):115-122. PubMed ID: 31746818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone loaded nanoparticles exert protective effects against Cisplatin-induced hearing loss by systemic administration.
    Sun C; Wang X; Chen D; Lin X; Yu D; Wu H
    Neurosci Lett; 2016 Apr; 619():142-8. PubMed ID: 26971701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone base conserves hearing from electrode trauma-induced hearing loss.
    Vivero RJ; Joseph DE; Angeli S; He J; Chen S; Eshraghi AA; Balkany TJ; Van de Water TR
    Laryngoscope; 2008 Nov; 118(11):2028-35. PubMed ID: 18818553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs.
    Yumusakhuylu AC; Yazici M; Sari M; Binnetoglu A; Kosemihal E; Akdas F; Sirvanci S; Yuksel M; Uneri C; Tutkun A
    Int J Pediatr Otorhinolaryngol; 2012 Mar; 76(3):404-8. PubMed ID: 22261612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV-mediated delivery of the caspase inhibitor XIAP protects against cisplatin ototoxicity.
    Cooper LB; Chan DK; Roediger FC; Shaffer BR; Fraser JF; Musatov S; Selesnick SH; Kaplitt MG
    Otol Neurotol; 2006 Jun; 27(4):484-90. PubMed ID: 16791039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone-loaded chitosan-based genipin-cross-linked hydrogel for prevention of cisplatin induced ototoxicity in Guinea pig model.
    Yüksel Aslıer NG; Tağaç AA; Durankaya SM; Çalışır M; Ersoy N; Kırkım G; Yurdakoç K; Bağrıyanık HA; Yılmaz O; Sütay S; Güneri EA
    Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():60-69. PubMed ID: 30974336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the protective effect of dexamethasone on cisplatin-induced ototoxicity in rats.
    Capelo IOJ; Batista AMA; Brito YNF; Diniz KB; Brito GAC; Freitas MR
    Acta Cir Bras; 2017 Oct; 32(10):873-880. PubMed ID: 29160374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity.
    Olgun Y; Kırkım G; Kolatan E; Kıray M; Bagrıyanık A; Olgun A; Kızmazoglu DC; Ellıdokuz H; Serbetcıoglu B; Altun Z; Aktas S; Yılmaz O; Günerı EA
    Laryngoscope; 2014 Mar; 124(3):760-6. PubMed ID: 23900991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are intratympanic injections of N-acetylcysteine and methylprednisolone protective against Cisplatin-induced ototoxicity?
    Saliba I; El Fata F; Ouelette V; Robitaille Y
    J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):236-43. PubMed ID: 20470667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone's effect in the retrocochlear auditory centers of a noise-induced hearing loss mouse model.
    Chen L; Dean C; Gandolfi M; Nahm E; Mattiace L; Kim AH
    Otolaryngol Head Neck Surg; 2014 Oct; 151(4):667-74. PubMed ID: 25113508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Sustained-Exposure Dexamethasone Formulation OTO-104 Offers Effective Protection against Cisplatin-Induced Hearing Loss.
    Fernandez R; Harrop-Jones A; Wang X; Dellamary L; LeBel C; Piu F
    Audiol Neurootol; 2016; 21(1):22-9. PubMed ID: 26789647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does intracochlear brain-derived nerve growth factor improve auditory brainstem click thresholds in sensorineural hearing loss?
    Meen E; Blakley B; Quddusi T
    J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):232-5. PubMed ID: 20470666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic dexamethasone for the prevention of cisplatin-induced ototoxicity.
    Waissbluth S; Salehi P; He X; Daniel SJ
    Eur Arch Otorhinolaryngol; 2013 May; 270(5):1597-605. PubMed ID: 22907029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.